Yes it is: The future of health is female

Two years on from the reversal of Roe v. Wade in the US, the women's healthtech industry is at a critical inflection point. The US markets lead the way when it comes to tech investment, but women's health remains massively under-invested. Despite women constituting 50% of the population, a mere 1% of healthcare research and innovation investment is directed towards female-specific conditions beyond oncology. Now more than ever, broader, bolder conversations around women's health are needed to address the innumerable areas where women's health needs investment and attention, above and beyond fertility.